4-HO-MiPT 20 MG granulki
Właściwości peletek 4-HO-MiPT
Synonim: Fumaran 4-hydroksy-N-metylo-N-izopropylotryptaminy
Numer CAS: 77872-43-6
Formuła: 3-[2-(isopropyl(methyl)amino)ethyl]-1H-indole-4-ol fumarate
Masa molowa: 348,4 g/mol
Czystość: >97%
€24.95 – €259.95Zakres cen: od €24.95 do €259.95
* Informacje na tej stronie stanowią podsumowanie i nie obejmują wszystkich dostępnych informacji na temat tego leku. Nie obejmują one wszystkich możliwych zastosowań, sposobów użycia, środków ostrożności, interakcji z innymi lekami ani działań niepożądanych i nie zastępują wiedzy i osądu lekarza.
4-HO-MiPT 20 MG Pellets – Psychedelic Tryptamine for Advanced Laboratory Research
Nazwa produktu: 4-HO-MiPT (4-Hydroxy-N-methyl-N-isopropyltryptamine)
Form: 20 mg pressed pellets
Chemical Class: Tryptamine, serotonergic psychedelics
Chemical Formula: C13H18N2O
Molecular Mass: 218,30 g/mol
Czystość: ≥ 98% (HPLC Validated)
Przeznaczenie: For scientific and analytical use only
Description
4-HO-MiPT is a synthetic psychedelic tryptamine and a structural analog of psilocin (the active ingredient in magic mushrooms). Due to the addition of a methyl and isopropyl group to the nitrogen atom, 4-HO-MiPT has a unique pharmacological profile, characterized by intense sensory modulation and cognitive stimulation in animal studies.
Ten 20 MG Pellets are carefully formulated for easy and reproducible laboratory use. This substance allows researchers to analyze the structural function of hydroxyltryptamines, as well as receptor interactions within the serotonergic system.
Applications in Scientific Research
🔬 Badania wiązania receptora (especially 5-HT2A, 5-HT1A)
🔬 Neuropharmacological behavioral studies in non-human models
🔬 Structural comparison studies between psilocin, MiPT and related compounds
🔬 LC-MS/GC-MS calibration and reference use
🔬 Prodrug metabolite activity studies
Advantages for Laboratory Application
✅ Dokładne dawkowanie – Each pellet contains exactly 20 mg
✅ Stable form – Suitable for long-term storage
✅ Rapid solubility in ethanol and DMSO for assays
✅ Wysoka czystość – Suitable for reproducible results
Disadvantages and Risks
⚠️ Light sensitivity – Requires dark and dry storage
⚠️ Potentially unstable in solution with prolonged exposure to moisture
⚠️ Limited toxicological data w wyższych dawkach
⚠️ Not approved for human consumption or therapeutic use
Use & Storage (Laboratory Scenarios)
- Recommended starting dose (in vitro): 1–5 mg per 10 ml buffer
- Rozpuszczalność: Freely soluble in ethanol, moderately soluble in water
- Warunki przechowywania: Dry, light-proof, preferably at 2–8°C
- Handling advice: Wear protective equipment and use under a fume hood.
Batch data – Laboratory report
| Parametr | Specification |
|---|---|
| Batch number | 4HOMIPT-0725 |
| Purity (HPLC) | 98.5% |
| Identification | Confirmed by NMR & Mass Spectrometry |
| Physical form | White to light gray pellet |
| Temperatura topnienia | 183–186 °C |
Często zadawane pytania (FAQ)
❓ What is the difference between 4-HO-MiPT and psilocin?
➡️4-HO-MiPT is a synthetic variant with a different substitution on the nitrogen atom. This results in a different receptor profile and potentially a different duration of action in animal models.
❓ Is 4-HO-MiPT legal?
➡️The substance is not specifically regulated in many countries (including the Netherlands), but is intended solely for research purposes . Always consult local regulations.
❓ Can 4-HO-MiPT be stored long-term?
➡️Yes. For optimal stability: store in an airtight container in a cool place (<8°C), away from light.
❓ Is it suitable for microdosing experiments?
➡️Not for human use. For low-dose laboratory studies, microdosing can be simulated in in vitro setups.
❓ What are typical observations in animal models?
➡️In previously published experiments: increased locomotor activity, pupil dilation and increased brain activity in frontal cortex (at controlled doses).
Warning
🚫 Not for human consumption. For laboratory and research use only.
Use only under the supervision of qualified personnel in a certified research setting.
